집
윤리적 의사결정 지원
철학/종교
28
28
공리주의와 의무론적 틀을 사용하여 비즈니스 결정의 도덕적 영향을 평가하고 규정 준수 조언을 제공합니다.
프롬프트 내용
복사
복사
Act as a corporate ethics consultant to assess the moral risks of the following business scenario: A pharmaceutical company discovers its best-selling drug has minor but under-disclosed side effects with long-term use. Continuing sales maintains stock price and jobs for thousands, but hiding information may harm some patients. Analyze the ethical tension between utilitarianism's focus on overall well-being and deontology's emphasis on the duty of honesty, and provide balanced advice that balances legal compliance with corporate social responsibility, ensuring the output is a natural flowing paragraph rather than a list.
복사
다음 비즈니스 시나리오의 도덕적 위험을 평가하기 위해 기업 윤고문으로 행동하십시오. 제약회사는 장기 복용 시 경미하지만 충분히 공개되지 않은 부작용이 있는 베스트셀러 의약품을 발견했습니다. 판매를 계속하면 주가와 수천 명의 고용이 유지되지만 정보를 숨기면 일부 환자에게 해를 끼칠 수 있습니다. 전반적인 복지에 초점을 맞춘 공리주의와 성실의 의무를 강조하는 의무론 사이의 윤리적 긴장을 분석하고 법적 준수와 기업의 사회적 책임 사이의 균형을 맞추는 균형 잡힌 조언을 제공하십시오. 출력은 목록이 아닌 자연스러운 흐름의 단락이어야 합니다.
복사
의견 (0)
0/300
추천
윤리적 의사결정 지원
Act as a corporate ethics committee to conduct a deep ethical assessment of the following specific business scenario: A major pharmaceutical company discovers that its best-selling drug has minor but negligible side effects with long-term use, yet discontinuing it would cause some patients' conditions to worsen. Combine the utilitarian principle of the greatest happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent to analyze the moral weight of three strategies: concealing information, issuing public warnings, or initiating a recall. Avoid simple right-or-wrong judgments; instead, construct a multi-dimensional evaluation framework including stakeholder impact, legal risks, brand reputation, and social trust. Finally, output an advisory action guide that aims to balance business sustainability with patient welfare, ensuring the decision-making process is transparent and adheres to the highest ethical standards.
윤리적 의사결정 지원
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but non-fatal side effects with long-term use, yet a recall would bankrupt the company and lay off thousands. Evaluate the ethical weights of recalling versus not recalling by combining utilitarian calculations for the greatest good with deontological respect for human dignity, and provide a specific action plan that balances social responsibility with corporate survival, focusing on how to build public trust through transparent communication.
윤리적 의사결정 지원
Act as a corporate ethics consultant to analyze the moral dilemma in the following business scenario: A pharmaceutical company discovers that its best-selling drug has minor but negligible side effects with long-term use, yet discontinuing it would cause some patients' conditions to worsen. Please weigh the benefits of disclosure against the risks of concealment, combining utilitarian consequence assessment with deontological respect for informed consent. Finally, provide a specific action plan that balances patient safety, corporate reputation, and legal compliance, focusing on how to maintain trust through transparent communication while minimizing potential harm.
윤리적 의사결정 지원
Act as a corporate ethics consultant to conduct a deep moral deduction on the following specific business scenario: A pharmaceutical company discovers that its marketed drug has mild but irreversible neurological side effects with long-term use, yet stopping medication carries higher risks and alternative therapies are less effective. Please analyze the ethical weight of four strategies—disclosing information, adjusting pricing, reformulating, or withdrawing from the market—by balancing utilitarian calculations for the greatest good against deontological adherence to patient知情权 and non-maleficence. Provide a final action recommendation that balances business sustainability with social responsibility, focusing on how to build trust through transparency and patient safety.
윤리적 의사결정 지원
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its long-listed common drug may cause severe side effects in a very small group of patients with specific genetic profiles, but the recall cost is extremely high and could lead to drug shortages affecting the majority of patients. Please evaluate the moral rationality of three options—full recall, partial recall, or continued sales—by combining the utilitarian principle of maximizing happiness with the deontological obligation to respect individual rights and the duty of honest disclosure. Provide the best course of action that balances the interests of all parties and aligns with corporate social responsibility, focusing on the ethical trade-off logic in the decision-making process.
윤리적 의사결정 지원
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug has minor but predictable side effects with long-term use, yet stopping production would leave millions of dependent patients without basic treatment. Please evaluate whether the drug should be voluntarily recalled by combining the utilitarian principle of the greatest happiness for the greatest number with the deontological duty to honestly inform patients of risks. In your analysis, weigh shareholder interests, patient safety, legal compliance, and social trust, and provide a specific action recommendation that balances ethical responsibility with business sustainability, avoiding abstract theoretical stacking and focusing on the practical execution level of ethical trade-offs.
